Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. Founded in 2017, Theolytics is backed by investors that include Oxford Sciences Innovation, Epidarex Capital, and Taiho Ventures and is headquartered in Oxford.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Medical, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
